Evidence map›Paper›PMID 27573839›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination.

Sophie V Pageon, Thibault Tabarin, Yui Yamamoto, Yuanqing Ma, Philip R Nicovich, John S Bridgeman, André Cohnen, Carola Benzing, Yijun Gao, Michael D Crowther and 10 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 239 citations in OpenAlex.

  1. High-Fat Diet Remodels Plasma Membrane Rigidity to Potentiate Colonocyte Stemness in Mice.Cellular and molecular gastroenterology and hepatology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. IL-2 Free Expansion of T Cells with Immunofilaments.Advanced healthcare materials · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. From Biophysics to Biomedical Physics.ACS bio & med chem Au · 2025
    Review
  16. Article
  17. Article
  18. Cell-Membrane-Anchored DNA Nanoplatform for Programming Cellular Interactions.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  19. Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Sophie V PageonEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia;ORCID 0000-0003-1701-5551
Thibault TabarinEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia;
Yui YamamotoEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia;
Yuanqing MaEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia;
Philip R Nicovich
John S BridgemanInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom; Cellular Therapeutics Ltd., Manchester M13 9XX, United Kingdom;
André CohnenT Cell Signalling Laboratory, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom;
Carola BenzingEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia;
Yijun GaoEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia;
Michael D CrowtherInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom;
Katie TungattInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom;
Garry DoltonInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom;
Andrew K SewellInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom;
David A PriceInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
Oreste AcutoT Cell Signalling Laboratory, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom;
Robert G PartonInstitute for Molecular Bioscience, University of Queensland, St. Lucia, QLD 4072, Australia; Australia Centre for Microscopy and Microanalysis, University of Queensland, St. Lucia, QLD 4072, Australia; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, St. Lucia, QLD 4072, Australia;
J Justin GoodingAustralian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Queensland, St. Lucia, QLD 4072, Australia; School of Chemistry and Australian Centre of NanoMedicine, University of New South Wales, Sydney, NSW 2052, Australia;
Jérémie RossyEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia;
Jamie RossjohnInstitute of Infection and Immunity, Cardiff University School of Medicine, Cardiff CF14 4XN, United Kingdom; Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC 3800, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, VIC 3800, Australia.
Katharina GausEuropean Molecular Biology Laboratory (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW 2052, Australia; k.gaus@unsw.edu.au.
Australian Research Council · AUCardiff University · GBUniversity of Oxford · GBCellular Therapeutics (United Kingdom) · GBNational Institutes of Health · US

Funding

Wellcome Trust 200844/Z/16/Z
6 · The paper itself

Abstract

Antigen recognition by the T-cell receptor (TCR) is a hallmark of the adaptive immune system. When the TCR engages a peptide bound to the restricting major histocompatibility complex molecule (pMHC), it transmits a signal via the associated CD3 complex. How the extracellular antigen recognition event leads to intracellular phosphorylation remains unclear. Here, we used single-molecule localization microscopy to quantify the organization of TCR-CD3 complexes into nanoscale clusters and to distinguish between triggered and nontriggered TCR-CD3 complexes. We found that only TCR-CD3 complexes in dense clusters were phosphorylated and associated with downstream signaling proteins, demonstrating that the molecular density within clusters dictates signal initiation. Moreover, both pMHC dose and TCR-pMHC affinity determined the density of TCR-CD3 clusters, which scaled with overall phosphorylation levels. Thus, TCR-CD3 clustering translates antigen recognition by the TCR into signal initiation by the CD3 complex, and the formation of dense signaling-competent clusters is a process of antigen discrimination.

Indexed as

Adaptive ImmunityAnimalsAntigensCD3 ComplexHumansMajor Histocompatibility ComplexMicePeptidesPhosphorylationReceptors, Antigen, T-CellSignal TransductionSingle Molecule ImagingAntigensCD3 ComplexPeptidesReceptors, Antigen, T-Cellsignal transductionsingle-molecule localization microscopyTCR triggering

Identifiers

PMID27573839
PMCPMC5027455
OpenAlexW2514687378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.